Analysed SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ) News Sources
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
09-04-2026
yahoo.com
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
30-03-2026
yahoo.com
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17-03-2026
yahoo.com
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
18-02-2026
yahoo.com
Sensei to ditch its lead candidate and cut workforce amidst strategic review
31-10-2025
pharmaceutical-technology.com
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
30-10-2025
yahoo.com
Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025
17-10-2025
yahoo.com
What is the current price of SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ)?
The current price of SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ) is $29.89.
SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ) absolute price change since previous trading day?
The absolute price change of SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ) since the previous trading day is $-0.64.
SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ) percentage price change since previous trading day?
The percentage price change of SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ) since the previous trading day is -2.0963%.
What is the most recent average sentiment score for SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ)?
The most recent average sentiment score for SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ)?
The most recent sentiment for SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ) is .
SEC-8K** Filing Available For SENSEI BIOTHERAPEUTICS INC (SNSE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.